Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG

Susan M. Bueno, Pablo A. González, Kelly M. Cautivo, Jorge E. Mora, Eduardo D. Leiva, Hugo E. Tobar, Glenn J. Fennelly, Eliseo Eugenin, William R. Jacobs, Claudia A. Riedel, Alexis M. Kalergis

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Respiratory syncytial virus (RSV) is one of the leading causes of childhood hospitalization and a major health burden worldwide. Unfortunately, because of an inefficient immunological memory, RSV infection provides limited immune protection against reinfection. Furthermore, RSV can induce an inadequate Th2-type immune response that causes severe respiratory tract inflammation and obstruction. It is thought that effective RSV clearance requires the induction of balanced Th1-type immunity, involving the activation of IFN-γ-secreting cytotoxic T cells. A recognized inducer of Th1 immunity is Mycobacterium bovis bacillus Calmette-Guérin (BCG), which has been used in newborns for decades in several countries as a tuberculosis vaccine. Here, we show that immunization with recombinant BCG strains expressing RSV antigens promotes protective Th1-type immunity against RSV in mice. Activation of RSV-specific T cells producing IFN-γ and IL-2 was efficiently obtained after immunization with recombinant BCG. This type of T cell immunity was protective against RSV challenge and caused a significant reduction of inflammatory cell infiltration in the airways. Furthermore, mice immunized with recombinant BCG showed no weight loss and reduced lung viral loads. These data strongly support recombinant BCG as an efficient vaccine against RSV because of its capacity to promote protective Th1 immunity.

Original languageEnglish (US)
Pages (from-to)20822-20827
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume105
Issue number52
DOIs
StatePublished - Dec 30 2008
Externally publishedYes

Fingerprint

Respiratory Syncytial Viruses
Bacillus
Immunity
T-Lymphocytes
Immunization
Respiratory Syncytial Virus Vaccines
Tuberculosis Vaccines
Immunologic Memory
Respiratory Syncytial Virus Infections
Mycobacterium bovis
Viral Load
Respiratory System
Interleukin-2
Weight Loss
Hospitalization
Inflammation
Antigens
Lung

Keywords

  • Immunopathology
  • RSV
  • T cell immunity
  • Th1 cell response

ASJC Scopus subject areas

  • General

Cite this

Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. / Bueno, Susan M.; González, Pablo A.; Cautivo, Kelly M.; Mora, Jorge E.; Leiva, Eduardo D.; Tobar, Hugo E.; Fennelly, Glenn J.; Eugenin, Eliseo; Jacobs, William R.; Riedel, Claudia A.; Kalergis, Alexis M.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, No. 52, 30.12.2008, p. 20822-20827.

Research output: Contribution to journalArticle

Bueno, SM, González, PA, Cautivo, KM, Mora, JE, Leiva, ED, Tobar, HE, Fennelly, GJ, Eugenin, E, Jacobs, WR, Riedel, CA & Kalergis, AM 2008, 'Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG', Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 52, pp. 20822-20827. https://doi.org/10.1073/pnas.0806244105
Bueno, Susan M. ; González, Pablo A. ; Cautivo, Kelly M. ; Mora, Jorge E. ; Leiva, Eduardo D. ; Tobar, Hugo E. ; Fennelly, Glenn J. ; Eugenin, Eliseo ; Jacobs, William R. ; Riedel, Claudia A. ; Kalergis, Alexis M. / Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. In: Proceedings of the National Academy of Sciences of the United States of America. 2008 ; Vol. 105, No. 52. pp. 20822-20827.
@article{799c1ec4eebe4eb69d2184064d3d6b06,
title = "Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG",
abstract = "Respiratory syncytial virus (RSV) is one of the leading causes of childhood hospitalization and a major health burden worldwide. Unfortunately, because of an inefficient immunological memory, RSV infection provides limited immune protection against reinfection. Furthermore, RSV can induce an inadequate Th2-type immune response that causes severe respiratory tract inflammation and obstruction. It is thought that effective RSV clearance requires the induction of balanced Th1-type immunity, involving the activation of IFN-γ-secreting cytotoxic T cells. A recognized inducer of Th1 immunity is Mycobacterium bovis bacillus Calmette-Gu{\'e}rin (BCG), which has been used in newborns for decades in several countries as a tuberculosis vaccine. Here, we show that immunization with recombinant BCG strains expressing RSV antigens promotes protective Th1-type immunity against RSV in mice. Activation of RSV-specific T cells producing IFN-γ and IL-2 was efficiently obtained after immunization with recombinant BCG. This type of T cell immunity was protective against RSV challenge and caused a significant reduction of inflammatory cell infiltration in the airways. Furthermore, mice immunized with recombinant BCG showed no weight loss and reduced lung viral loads. These data strongly support recombinant BCG as an efficient vaccine against RSV because of its capacity to promote protective Th1 immunity.",
keywords = "Immunopathology, RSV, T cell immunity, Th1 cell response",
author = "Bueno, {Susan M.} and Gonz{\'a}lez, {Pablo A.} and Cautivo, {Kelly M.} and Mora, {Jorge E.} and Leiva, {Eduardo D.} and Tobar, {Hugo E.} and Fennelly, {Glenn J.} and Eliseo Eugenin and Jacobs, {William R.} and Riedel, {Claudia A.} and Kalergis, {Alexis M.}",
year = "2008",
month = "12",
day = "30",
doi = "10.1073/pnas.0806244105",
language = "English (US)",
volume = "105",
pages = "20822--20827",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "52",

}

TY - JOUR

T1 - Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG

AU - Bueno, Susan M.

AU - González, Pablo A.

AU - Cautivo, Kelly M.

AU - Mora, Jorge E.

AU - Leiva, Eduardo D.

AU - Tobar, Hugo E.

AU - Fennelly, Glenn J.

AU - Eugenin, Eliseo

AU - Jacobs, William R.

AU - Riedel, Claudia A.

AU - Kalergis, Alexis M.

PY - 2008/12/30

Y1 - 2008/12/30

N2 - Respiratory syncytial virus (RSV) is one of the leading causes of childhood hospitalization and a major health burden worldwide. Unfortunately, because of an inefficient immunological memory, RSV infection provides limited immune protection against reinfection. Furthermore, RSV can induce an inadequate Th2-type immune response that causes severe respiratory tract inflammation and obstruction. It is thought that effective RSV clearance requires the induction of balanced Th1-type immunity, involving the activation of IFN-γ-secreting cytotoxic T cells. A recognized inducer of Th1 immunity is Mycobacterium bovis bacillus Calmette-Guérin (BCG), which has been used in newborns for decades in several countries as a tuberculosis vaccine. Here, we show that immunization with recombinant BCG strains expressing RSV antigens promotes protective Th1-type immunity against RSV in mice. Activation of RSV-specific T cells producing IFN-γ and IL-2 was efficiently obtained after immunization with recombinant BCG. This type of T cell immunity was protective against RSV challenge and caused a significant reduction of inflammatory cell infiltration in the airways. Furthermore, mice immunized with recombinant BCG showed no weight loss and reduced lung viral loads. These data strongly support recombinant BCG as an efficient vaccine against RSV because of its capacity to promote protective Th1 immunity.

AB - Respiratory syncytial virus (RSV) is one of the leading causes of childhood hospitalization and a major health burden worldwide. Unfortunately, because of an inefficient immunological memory, RSV infection provides limited immune protection against reinfection. Furthermore, RSV can induce an inadequate Th2-type immune response that causes severe respiratory tract inflammation and obstruction. It is thought that effective RSV clearance requires the induction of balanced Th1-type immunity, involving the activation of IFN-γ-secreting cytotoxic T cells. A recognized inducer of Th1 immunity is Mycobacterium bovis bacillus Calmette-Guérin (BCG), which has been used in newborns for decades in several countries as a tuberculosis vaccine. Here, we show that immunization with recombinant BCG strains expressing RSV antigens promotes protective Th1-type immunity against RSV in mice. Activation of RSV-specific T cells producing IFN-γ and IL-2 was efficiently obtained after immunization with recombinant BCG. This type of T cell immunity was protective against RSV challenge and caused a significant reduction of inflammatory cell infiltration in the airways. Furthermore, mice immunized with recombinant BCG showed no weight loss and reduced lung viral loads. These data strongly support recombinant BCG as an efficient vaccine against RSV because of its capacity to promote protective Th1 immunity.

KW - Immunopathology

KW - RSV

KW - T cell immunity

KW - Th1 cell response

UR - http://www.scopus.com/inward/record.url?scp=58549103296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58549103296&partnerID=8YFLogxK

U2 - 10.1073/pnas.0806244105

DO - 10.1073/pnas.0806244105

M3 - Article

C2 - 19075247

AN - SCOPUS:58549103296

VL - 105

SP - 20822

EP - 20827

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 52

ER -